In a nutshell: The Creighton Model FertilityCare System relies on a woman’s observations of her cervical mucus to determine the fertile and infertile days in her menstrual cycle.
The Creighton Model is a natural and holistic approach to a woman’s fertility health. Women and couples are taught to observe and track natural biological markers (cervical mucus) in a woman’s menstrual cycle to understand the normal function of the reproductive system. The system is designed for use according to the intention of the couple in order to achieve a pregnancy, avoid pregnancy, or simply to monitor gynecological health.
The Creighton Model is taught one on one with a FertilityCare Practitioner. The teachers of the Creighton Model are trained allied health professionals and specially-trained physicians have been educated to incorporate the Creighton Model into their medical practice (with the use of NaPro Technology).
The Creighton Model is standardized, easy to learn, medically safe, reliable, and inexpensive. It can be used anytime during a woman’s reproductive life and is effective even with irregular cycles, during breastfeeding, and menopause.
In cooperation with NaPro Technology, the Creighton Model can assist in the diagnosis and treatment of many gynecologic conditions including PMS, endometriosis, recurrent miscarriage, infertility, PCOS, and more.
NaProTECHNOLOGY relies on theThe Creighton Model System biomarkers to monitor easily and objectively the occurrence of various hormonal events during the menstrual cycle. CrMS provides valid information that can be interpreted by a woman and by physicians who are specifically trained in this system.
NaProTECHNOLOGY identifies the problems and cooperates with the menstrual and fertility cycles that correct the condition, maintain the human ecology, and sustain the procreative potential. It has many applications including the evaluation and treatment of infertility and other reproductive disorders, abnormal bleeding, abnormal hormone conditions of the menstrual cycle including premenstrual syndrome and recurrent ovarian cysts, the dating and beginning of pregnancy, and postpartum depression.